Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Allan Jordan, PhD, Author at Contract Pharma

What are you searching for?

Sign in

Allan Jordan, PhD

VP, Oncology Drug Discovery
Sygnature Discovery

Allan joined Sygnature Discovery in February 2019 as Vice President of Oncology Drug Discovery, delivering broad scientific oversight and mentorship of all Sygnature’s oncology projects. With 25+ years’ experience in medicinal chemistry and drug discovery, he has actively participated in almost 60 drug discovery projects, resulting in the delivery of fifteen pre-clinical candidates of which ten have entered human clinical trials. He led the chemistry teams which developed the first cell-active inhibitors of the DNA repair protein PARG, now in Phase I trials with Ideaya Biosciences and the first reversible, selective inhibitors of the epigenetic enzyme DNMT-1, in collaboration with GSK.

Latest by Allan Jordan, PhD

Search By Type
  • Exclusives